A $3,000 diversified portfolio across AT&T, Verizon, and Pfizer generates approximately $167 in annual passive income, providing investors with high yields and full same-day liquidity.
Verizon raised its 2026 adjusted EPS guidance to $4.99-$5.04, covers the $2.83 annualized dividend, and extended its dividend increase streak to 20 consecutive years.
AT&T's dividend appears covered by adjusted EPS guidance of $2.25-$2.35 against a $1.11 annualized payout, with fiber growth and CFO comments supporting dividend sustainability.
Pfizer's 2026 adjusted EPS guidance of $2.80-$3.00 covers the $1.72 annualized dividend, though GAAP earnings are thin and COVID product revenues declined sharply.
AT&T, Verizon, and Pfizer offer income-focused investors a combined 5.45% yield with a $3,000 investment. While each stock trades below $50, their dividends remain supported by adjusted earnings guidance despite sector-specific headwinds like debt loads and patent cliffs.
Management teams for all three companies have publicly affirmed their commitment to maintaining dividends, with current adjusted EPS guidance covering the annualized payouts for each firm.